Vulnerability Description
In Patient Information Center iX (PICiX) Version B.02, C.02, C.03, and PerformanceBridge Focal Point Version A.01, when an actor claims to have a given identity, the software does not prove or insufficiently proves the claim is correct.
CVSS Score
HIGH
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Philips | Patient Information Center Ix | b.02 |
| Philips | Performancebridge Focal Point | a.01 |
Related Weaknesses (CWE)
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-254-01Third Party AdvisoryUS Government Resource
- https://www.philips.com/productsecurity
- https://us-cert.cisa.gov/ics/advisories/icsma-20-254-01Third Party AdvisoryUS Government Resource
- https://www.philips.com/productsecurity
FAQ
What is CVE-2020-16222?
CVE-2020-16222 is a vulnerability with a CVSS score of 8.8 (HIGH). In Patient Information Center iX (PICiX) Version B.02, C.02, C.03, and PerformanceBridge Focal Point Version A.01, when an actor claims to have a given identity, the software does not prove or insuf...
How severe is CVE-2020-16222?
CVE-2020-16222 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2020-16222?
Check the references section above for vendor advisories and patch information. Affected products include: Philips Patient Information Center Ix, Philips Performancebridge Focal Point.